Clinical Trial Update: Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing HOE490 O (glimepiride/metformin) versus placebo as an add-on to ongoing glimepiride therapy in adults with Type 2 Diabetes Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HOE490 O (glimepiride/metformin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED